Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ) has issued an announcement.
Hangzhou Tigermed Consulting Co., Ltd. has established a Remuneration and Evaluation Committee to improve its corporate governance structure. This committee is responsible for formulating evaluation standards and remuneration policies for directors and senior management, ensuring accountability to the board of directors. The committee’s establishment is expected to enhance transparency and formalize procedures for remuneration policies, potentially impacting the company’s operational efficiency and stakeholder trust.
The most recent analyst rating on (HK:3347) stock is a Sell with a HK$37.00 price target. To see the full list of analyst forecasts on Hangzhou Tigermed Consulting Co., Ltd. Class H stock, see the HK:3347 Stock Forecast page.
More about Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co., Ltd. operates in the consulting industry, focusing on providing evaluation and remuneration services for directors and senior management members. The company aims to enhance corporate governance through structured evaluation and remuneration systems.
Average Trading Volume: 4,878,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$55.09B
Find detailed analytics on 3347 stock on TipRanks’ Stock Analysis page.